170 related articles for article (PubMed ID: 32731241)
1. The Evolving Role of Systemic Therapy in the Primary Treatment of Sinonasal Cancer.
Licitra L; Resteghini C; Bossi P
Adv Otorhinolaryngol; 2020; 84():78-86. PubMed ID: 32731241
[TBL] [Abstract][Full Text] [Related]
2. The role of systemic therapy in the management of sinonasal cancer: A critical review.
Bossi P; Saba NF; Vermorken JB; Strojan P; Pala L; de Bree R; Rodrigo JP; Lopez F; Hanna EY; Haigentz M; Takes RP; Slootweg PJ; Silver CE; Rinaldo A; Ferlito A
Cancer Treat Rev; 2015 Dec; 41(10):836-43. PubMed ID: 26255226
[TBL] [Abstract][Full Text] [Related]
3. Locally advanced epithelial sinonasal tumors: The impact of multimodal approach.
Orlandi E; Cavalieri S; Granata R; Nicolai P; Castelnuovo P; Piazza C; Schreiber A; Turri-Zanoni M; Quattrone P; Miceli R; Infante G; Sessa F; Facco C; Calareso G; Iacovelli NA; Mattavelli D; Paderno A; Resteghini C; Locati LD; Licitra L; Bossi P
Laryngoscope; 2020 Apr; 130(4):857-865. PubMed ID: 31369156
[TBL] [Abstract][Full Text] [Related]
4. Sinonasal malignancies with neuroendocrine differentiation: patterns of failure according to histologic phenotype.
Rosenthal DI; Barker JL; El-Naggar AK; Glisson BS; Kies MS; Diaz EM; Clayman GL; Demonte F; Selek U; Morrison WH; Ang KK; Chao KS; Garden AS
Cancer; 2004 Dec; 101(11):2567-73. PubMed ID: 15517582
[TBL] [Abstract][Full Text] [Related]
5. Multimodality therapy in advanced paranasal sinus carcinoma: superior long-term results.
Lee MM; Vokes EE; Rosen A; Witt ME; Weichselbaum RR; Haraf DJ
Cancer J Sci Am; 1999; 5(4):219-23. PubMed ID: 10439167
[TBL] [Abstract][Full Text] [Related]
6. Cavernous sinus involvement is not a risk factor for the primary tumor site treatment outcome of Sinonasal adenoid cystic carcinoma.
Lee YC; Lee TJ; Tsang NM; Huang Y; Hsu CL; Hsin LJ; Lee YH; Chang KP
J Otolaryngol Head Neck Surg; 2018 Feb; 47(1):12. PubMed ID: 29402308
[TBL] [Abstract][Full Text] [Related]
7. Treatment outcomes of concurrent chemoradiotherapy for locally advanced sinonasal squamous cell carcinoma: A single-institution study.
Kim JH; Lee YS; Chung YS; Jang YJ; Kim SB; Lee SW; Lee BJ
Acta Otolaryngol; 2015; 135(11):1189-95. PubMed ID: 26112831
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of nonsurgical management of locally advanced carcinomas of the sinonasal cavity.
Chopra S; Kamdar DP; Cohen DS; Heilbrun LK; Smith D; Kim H; Lin HS; Jacobs JR; Yoo G
Laryngoscope; 2017 Apr; 127(4):855-861. PubMed ID: 27859278
[TBL] [Abstract][Full Text] [Related]
9. Favorable long-term survival following induction chemotherapy with cisplatin, fluorouracil, and leucovorin and concomitant chemoradiotherapy for locally advanced head and neck cancer.
Vokes EE; Weichselbaum RR; Mick R; McEvilly JM; Haraf DJ; Panje WR
J Natl Cancer Inst; 1992 Jun; 84(11):877-82. PubMed ID: 1375657
[TBL] [Abstract][Full Text] [Related]
10. [Diagnosis, prognosis and treatment of sinonasal carcinomas (excluding melanomas, sarcomas and lymphomas)].
Thariat J; Moya Plana A; Vérillaud B; Vergez S; Régis-Ferrand F; Digue L; Even C; Costes V; Baujat B; de Gabory L; Baglin AC; Janot F;
Bull Cancer; 2020 May; 107(5):601-611. PubMed ID: 32305127
[TBL] [Abstract][Full Text] [Related]
11. Sinonasal undifferentiated carcinoma: an update.
Enepekides DJ
Curr Opin Otolaryngol Head Neck Surg; 2005 Aug; 13(4):222-5. PubMed ID: 16012246
[TBL] [Abstract][Full Text] [Related]
12. Sinonasal cancers treatments: state of the art.
Ferrari M; Orlandi E; Bossi P
Curr Opin Oncol; 2021 May; 33(3):196-205. PubMed ID: 33756515
[TBL] [Abstract][Full Text] [Related]
13. A comprehensive comparative analysis of treatment modalities for sinonasal malignancies.
Robin TP; Jones BL; Gordon OM; Phan A; Abbott D; McDermott JD; Goddard JA; Raben D; Lanning RM; Karam SD
Cancer; 2017 Aug; 123(16):3040-3049. PubMed ID: 28369832
[TBL] [Abstract][Full Text] [Related]
14. Sinonasal Squamous Cell Carcinoma Outcomes: Does Treatment at a High-Volume Center Confer Survival Benefit?
Teitelbaum JI; Issa K; Barak IR; Ackall FY; Jung SH; Jang DW; Abi Hachem R
Otolaryngol Head Neck Surg; 2020 Nov; 163(5):986-991. PubMed ID: 32600116
[TBL] [Abstract][Full Text] [Related]
15. Multimodal Therapy for Sinonasal Malignancies: Updates and Review of Current Treatment.
Mody MD; Saba NF
Curr Treat Options Oncol; 2020 Jan; 21(1):4. PubMed ID: 31950286
[TBL] [Abstract][Full Text] [Related]
16. Paranasal sinus cancer.
Bossi P; Farina D; Gatta G; Lombardi D; Nicolai P; Orlandi E
Crit Rev Oncol Hematol; 2016 Feb; 98():45-61. PubMed ID: 26520459
[TBL] [Abstract][Full Text] [Related]
17. Prediction of TP53 status for primary cisplatin, fluorouracil, and leucovorin chemotherapy in ethmoid sinus intestinal-type adenocarcinoma.
Licitra L; Suardi S; Bossi P; Locati LD; Mariani L; Quattrone P; Lo Vullo S; Oggionni M; Olmi P; Cantù G; Pierotti MA; Pilotti S
J Clin Oncol; 2004 Dec; 22(24):4901-6. PubMed ID: 15611505
[TBL] [Abstract][Full Text] [Related]
18. A clinical study of multimodal treatment for orbital organ preservation in locally advanced squamous cell carcinoma of the nasal cavity and paranasal sinus.
Chen NX; Chen L; Wang JL; Wang JY; Yan F; Ma L; Zhang XX
Jpn J Clin Oncol; 2016 Aug; 46(8):727-34. PubMed ID: 27207888
[TBL] [Abstract][Full Text] [Related]
19. Patterns of failure after combined-modality approaches incorporating radiotherapy for sinonasal undifferentiated carcinoma of the head and neck.
Chen AM; Daly ME; El-Sayed I; Garcia J; Lee NY; Bucci MK; Kaplan MJ
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):338-43. PubMed ID: 18207030
[TBL] [Abstract][Full Text] [Related]
20. Contemporary Treatment Approaches to Sinonasal Mucosal Melanoma.
Amit M; Na'ara S; Hanna EY
Curr Oncol Rep; 2018 Feb; 20(2):10. PubMed ID: 29492677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
